Delivery Order SPE2DB24D1205-SPE2DB25FCYUH
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,173.54 for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia management. This competitively awarded, firm fixed-price contract was executed on August 4, 2025, with a completion date of August 5, 2025, and carries no set-aside designation. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $13,503.94 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia management. This firm fixed price contract, awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a non-competitive delivery order executed under an existing contract vehicle. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60 count) on August 4, 2025, with a ceiling value of $40,373.44. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 5, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,809.04 to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia management. This firm fixed-price contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $3,350.95 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used to treat cardiac arrhythmias. This competitive, non-set-aside contract was awarded on August 11, 2025, with an ultimate completion date of August 12, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order utilizes firm fixed pricing and represents a child contract under the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,167.80 to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia treatment. The contract was competitively awarded without a set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 15, 2025. Performance of this delivery order is based in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $1,605.56 to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia management. The contract was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, and utilized firm fixed pricing with no set-aside designation. This delivery order represents a competitive award under AmerisourceBergen's existing federal contract vehicle, reflecting the company's...
- The Defense Logistics Agency awarded a $51,938.18 delivery order to AmerisourceBergen Drug Corp for 60-tablet units of Multaq 400 mg tablets, a pharmaceutical product used in cardiac arrhythmia management. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 13, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia management. This firm fixed-price delivery order, valued at $6,234.74, was awarded on August 12, 2025, with an ultimate completion date of August 13, 2025. The award utilized no set-aside provisions and was competitively awarded to AmerisourceBergen's Corporate Office, headquartered in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,529.88 for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia treatment. Issued on August 8, 2025, with an ultimate completion date of August 11, 2025, this firm fixed-price contract represents a non-set-aside award made through open competition. The contractor's place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCYUHDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,801.61 for 60-count tablets of MULTAQ 400 mg, a pharmaceutical product used in cardiac arrhythmia management. The contract was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, utilizing firm fixed price terms. This delivery order was competitively awarded without set-aside restrictions and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. This delivery order is executed under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. The company, headquartered in Conshohocken, Pennsylvania, maintains significant capacity to fulfill federal medical procurement requirements through its extensive distribution network and demonstrated track record of delivering diverse pharmaceutical products across multiple therapeutic domains to defense and civilian federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.8k | 7/22/25 |